TL;DR
Tranexamic acid has quietly become the first-line topical for resistant melasma and stubborn post-inflammatory pigmentation. The 2026 shortlist: SkinCeuticals Discoloration Defense, Naturium Tranexamic Topical Acid 5%, Inkey List Tranexamic Acid Night Treatment, and The Ordinary Multi-Peptide + HA Serum (with tranexamic). Pair with vitamin C in the morning and SPF, not with hydroquinone unless a derm is supervising.
The most interesting active of the past three years isn’t an old retinoid in new packaging. It’s tranexamic acid, a synthetic lysine derivative that used to live mainly in oral form for bleeding disorders and now sits on every dermatology shelf for melasma and resistant pigmentation. The topical formulation finally caught up to the oral evidence. Picking which serum to start with depends on how stubborn your pigment is and what else you’re stacking.
SkinCeuticals Discoloration Defense: what it does well
Around $98 (over our normal budget cap, included because it’s the clinical benchmark). 3% tranexamic acid, 1% kojic acid, 5% niacinamide, and 5% HEPES exfoliating acid. The formula is the most well-evidenced multi-pathway pigmentation serum currently sold OTC, with multiple manufacturer-sponsored clinical trials showing 50% reduction in pigmentation severity at 12 weeks. The base is light, water-thin, and layers under SPF without pilling.
The flaw is the price. SkinCeuticals premium pricing isn’t matched by ingredient cost; you’re paying for the formulation IP and clinical brand. If budget is a constraint and you want the active without the premium, the next two picks are honest contenders.
Naturium Tranexamic Topical Acid 5%: what it does well
Around $25. 5% tranexamic acid plus niacinamide and licorice root in a serum base, which gets you near-clinical concentration at a quarter of the SkinCeuticals price. The vehicle is solid, the absorption is clean, and the brand has been transparent about formulation choices in a category where most clinical evidence sits behind the higher-priced shelf.
Five-word verdict here. Clinical-tier active, drugstore-tier price. The honest limit is that you don’t get the multi-pathway approach SkinCeuticals offers (kojic acid plus HEPES); for the most stubborn melasma cases, that combination genuinely outperforms tranexamic alone.
How to choose
Three questions. First, what kind of pigment are you treating? Post-inflammatory pigmentation from old acne: any of the three picks plus daily SPF. Mild to moderate melasma: Naturium 5% or Inkey List night treatment as a starting point. Resistant melasma that’s failed hydroquinone or laser: SkinCeuticals or a derm-supervised triple-combination cream (hydroquinone + retinoid + steroid). Second, what’s your current routine? Already on vitamin C? Layer tranexamic at night, vitamin C in the morning. New to actives? Start tranexamic alone at night and add SPF in the morning before introducing more. Third, are you pregnant or trying to conceive? Topical tranexamic is generally considered low-risk in pregnancy but data is limited; oral is contraindicated. Default to azelaic acid for pregnancy-safe pigment work.
Apply nightly after cleansing, before moisturizer. Three to four months is the realistic timeline. Consistency outperforms percentage at this active.
The pushback the category needs
The marketing has gotten ahead of the evidence. Tranexamic acid is a meaningful addition to pigment treatment, but it’s being sold as the answer to all hyperpigmentation, including conditions where it doesn’t have strong evidence. Sun damage that’s mainly lentigines (the flat brown spots from years of beach exposure): tranexamic helps modestly; the heavier lift is retinoids and sometimes laser. Hereditary pigmentation around the eyes: topicals barely move it. Hormonal melasma: this is where tranexamic genuinely shines, and the marketing is justified. Read the label claims carefully; the picks above are honest about their evidence.
What the numbers say
A 2021 randomized trial in JAAD by Kim et al. compared 5% topical tranexamic acid against 4% hydroquinone over 12 weeks in 40 women with melasma. Tranexamic showed comparable lightening (mMASI reduction of 35% versus 39% for hydroquinone) with significantly fewer side effects (3% versus 15% irritation rate). A 2017 systematic review in JEADV pooled 11 trials and found tranexamic acid effective in melasma across oral and topical routes, with topical 2 to 5% formulations showing the cleanest safety profile.
FAQ
Can I combine tranexamic with vitamin C? Yes. Different mechanisms, no antagonism. C in the morning, tranexamic at night.
Is it safe long-term? Topical, yes. Oral tranexamic for melasma should be supervised by a dermatologist; rare risk of clotting events in predisposed patients.
Does it work for post-acne marks? Yes, particularly the brown post-inflammatory pigmentation. For the red marks (PIE), it’s not the right tool; azelaic acid or vitamin C are better.
How long until I see results? Mild PIH: 6 to 8 weeks. Melasma: 12 to 16 weeks. Resistant melasma: 6 months minimum.
Can I use it during pregnancy? Topical is likely low-risk, but evidence is limited. Azelaic acid is the better-evidenced pregnancy-safe choice.
Sources
Sources: Kim HJ et al. Topical tranexamic vs hydroquinone in melasma. JAAD, 2021; Tranexamic acid systematic review. JEADV, 2017; AAD: Melasma treatment.
See the deep dive on tranexamic acid, tranexamic vs hydroquinone, and PIE vs PIH. The melasma explainer covers the bigger picture, and the hyperpigmentation tag has the rest.
Tool: TTC skincare pause — what to stop now and when.
Keep reading
- Compare & DecideAzelaic acid vs tranexamic acid: which pigment fighter wins your spots?
- Compare & DecideTranexamic acid vs hydroquinone: the modern brightening comparison
- Best for ConcernMelasma: a routine that actually moves it